Reports Q2 revenue $7.48M, consensus $6.43M. “This is one of the most exciting and consequential periods in our history, and I am proud to see the teams advancing our proprietary, AI-driven DeepView(TM) System for burn indication (“DeepView AI- Burn”) along multiple fronts, including clinical, developmental and commercial,” said Peter M. Carlson, CEO of Spectral AI. “The upcoming completion of enrollment at burn centers for our U.S. Burn Pivotal Study, continued development of both our cart-based device and the handheld diagnostic tool, and anticipation of our first commercial revenues in the U.K. later this year validate our vison and reinforce our strategic imperatives.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDAI:
- MDAI Upcoming Earnings Report: What to Expect?
- Spectral announces continuing progress for development of DeepView SnapShot M
- Spectral AI Announces Continuing Progress in Development of Handheld DeepView SnapShot M® for Military Field Use
- Spectral AI Schedules 2024 Second Quarter Financial Results and Conference Call
- Spectral AI announces total U.S, international portfolio has 26 granted patents